Toward a developmental neurobiology of autism

Mental Retardation and Developmental Disabilities Research Reviews

Volumn 10, Issue 4, 2004, Pages 303-317

  Polleux, Franck ^a   Lauder, Jean M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Autism; Cortex; Dendrite; Development; Dopamine; GABA; Gene expression; Glutamate; Interneurons; Mouse genetics; Neuroligin; Neuronal migration; Neurotransmitters; Norepinephrine; Patterning; Serotonin; Synaptogenesis

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN MONOAMINE; CATECHOLAMINE; GLUTAMIC ACID; NEUROTROPHIN; SEROTONIN;

AUTISM; BRAIN CORTEX; BRAIN DEVELOPMENT; CELL SUBPOPULATION; DENDRITIC CELL; DIZYGOTIC TWINS; EVOKED RESPONSE; GENE EXPRESSION PROFILING; GENE MUTATION; GENE SEGREGATION; HUMAN; NERVE EXCITABILITY; NEUROBIOLOGY; NEUROTRANSMITTER RELEASE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SYNAPTOGENESIS;

AUTISTIC DISORDER; BRAIN; BRAIN STEM; CEREBELLUM; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 19; CHROMOSOMES, HUMAN, PAIR 20; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION; GENETIC MARKERS; GLUTAMIC ACID; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 13444260704     PISSN: 10804013     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrdd.20044     Document Type: Review

References (204)

1. Abu-Khalil A, Fu L, Grove EA, et al. 2004. Wnt genes define distinct boundaries in the developing human brain: Implications for human forebrain patterning. J Comp Neurol 474: 276-288.
2. Agulhon C, Abitbol M, Bertrand D, Malafosse, A. 1999. Localization of mRNA for CHRNA7 in human fetal brain. Neuroreport 10:2223-2227.
3. Anderson GM, Horne WC, Chatterjee D, et al. 1990. The hyperserotonemia of autism. Ann N Y Acad Sci 600:331-340; discussion 341-332.
4. Anderson SA, Eisenstat DD, Shi L, et al. 1997. Interneuron migration from basal forebrain to neocortex: Dependence on D1x genes. Science 278:474-476.
5. Andres C. 2002. Molecular genetics and animal models in autistic disorder. Brain Res Bull 57:109-119.
6. Aoyagi T, Takekawa T, Fukai T. 2003. Gamma rhythmic bursts: Coherence control in networks of cortical pyramidal neurons. Neural Coinput 15:1035-1061.
7. Ashley-Koch A, Wolpert CM, Menold MM, et al. 1999. Genetic studies of autistic disorder and chromosome 7. Genomics 61:227-236.
8. Auranen M, Vanhala R, Varilo T, et al. 2002. A genomewide screen for autism-spectrum disorders: evidence for a major susceptibility locus on chromosome 3q25-27. Am J Hum Genet 71:777-790.
9. Aylward EH, Minshew NJ, Field K, et al. 2002. Effects of age on brain volume and head circumference in autism. Neurology 59:175-183.
10. Baader SL, Sanlioglu S, Berrebi AS, et al. 1998. Ectopic overexpression of engrailed-2 in cerebellar Purkinje cells causes restricted cell loss and retarded external germinal layer development at lobule junctions. J Neurosci 18:1763-1773.
11. Bacchelli E, Blasi F, Biondolillo M, et al. 2003. Screening of nine candidate genes for autism on chromosome 2q reveals rare nonsynonymous variants in the cAMP-GEFII gene. Mol Psychiatry 8:916-924.
12. Bailey A, Luthert P, Dean A, et al. 1998. A clinicopathological study of autism. Brain 121: 889-905.
13. Ballaban-Gil K, Tuchman R. 2000. Epilepsy and epileptiform EEG: Association with autism and language disorders. Ment Retard Dev Disabil Res Rev 6:300-308.
14. Barrett S, Beck JC, Bernier R, et al. 1999. An autosomal genomic screen for autism. Collaborative linkage study of autism. Am J Med Genet 88:609-615.
15. Belmonte MK, Cook EH, Anderson GM, et al. 2004. Autism as a disorder of neural information processing: Directions for research and targets for therapy. Mol Psychiatry 9:646-663.
16. Betancur C, Corbex M, Spielewoy C, et al. 2002. Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder. Mol Psychiatry 7:67-71.
17. Borodinsky LN, Root CM, Cronin JA, et al. 2004. Activity-dependent homeostatic specification of transmitter expression in embryonic neurons. Nature 429:523-530.
18. Brault V, Moore R, Kutsch S, et al. 2001. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development 128:1253-1264.
19. Briscoe J, Sussel L, Serup P, et al. 1999. Homeobox gene Nkx2.2 and specification of neuronal identity by graded Sonic hedgehog signalling. Nature 398:622-627.
20. Brock J, Brown CC, Boucher J, et al. 2002. The temporal binding deficit hypothesis of autism. Dev Psychopathol 14:209-224.
21. Buhl EH, Halasy K, Somogyi P. 1994. Diverse sources of hippocampal unitary inhibitory postsynaptic potentials and the number of synaptic release sites. Nature 368:823-828.
22. Buxbaum JD, Silverman J, Keddache M, et al. 2004. Linkage analysis for autism in subset families with obsessive-compulsive behaviors: evidence for an autism susceptibility gene on chromosome 1 and further support for susceptibility genes on chromosome 6 and 19. Mol Psychiatry 9:144-150.
23. Carlsson ML. 1998. Hypothesis: Is infantile autism a hypoglutamatergic disorder? Relevance of glutamate-serotonin interactions for pharmacotherapy. J Neural Transm 105:525-535.
24. Carlsson ML, Martin P, Nilsson M, et al. 1999. The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist than dopamine agonist-induced hyperactivity in mice. J Neural Transm 106: 123-129.
25. Casanova MF, Buxhoeveden DP, Switala AE, et al. 2002. Minicolumnar pathology in autism. Neurology 58:428-432.
26. Casarosa S, Fode C, Guillemot F. 1999. Mash1 regulates neurogenesis in the ventral telencephalon. Development 126:525-534.
27. Chen WG, Chang Q, Lin Y, et al. 2003. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302:885-889.
28. Chenn A, Walsh CA. 2002. Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 297(5580):365-369.
29. Chibuk TK, Bischof JM, Wevrick R. 2001. A necdin/MAGE-like gene in the chromosome 15 autism susceptibility region: expression, imprinting, and mapping of the human and mouse orthologues. BMC Genet 2:22.
30. Chih B, Afridi SK, Clark L, et al. 2004. Disorder-associated mutations lead to functional inactivation of neuroligins. Hum Mol Genet 13: 1471-1477.
31. Chugani DC. 2002. Role of altered brain serotonin mechanisms in autism. Mol Psychiatry 7 Suppl 2:S16-S17.
32. Chugani DC, Muzik O, Behen M, et al. 1999. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol 45:287-295.
33. Chugani DC, Muzik O, Rothermel R et al. 1997. Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann Neurol 42:666-669.
34. Cline HT. 2001. Dendritic arbor development and synaptogenesis. Curr Opin Neurobiol 11:118-126.
35. Cobb SR, Buhl EH, Halasy K, et al. 1995. Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. Nature 378:75-78.
36. Cohen I, Liu X, Schutz C, et al. 2003. Association of autism severity with a monoamine oxidase A functional polymorphism. Clin Genet 64: 190-197.
37. Cook EH Jr., Courchesne R, Lord C, et al. 1997. Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry 2:247-250.
38. Courchesne E. 1997. Brainstem, cerebellar and limbic neuroanatomical abnormalities in autism. Curr Opin Neurobiol 7:269-278.
39. Courchesne E, Carper R, Akshoomoff N. 2003. Evidence of brain overgrowth in the first year of life in autism. JAMA 290:337-344.
40. Courchesne E, Karns CM, Davis HR, et al. 2001. Unusual brain growth patterns in early life in patients with autistic disorder: An MRI study. Neurology 57:245-254.
41. Courchesne E, Yeung-Courchesne R, Press G, et al. 1988. Hypoplasia of cerebellar vermal lobules VI and VII in autism. N Engl J Med 318:1349-1354.
42. Coutinho AM, Oliveira G, Morgadinho T, et al. 2004. Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism. Mol Psychiatry 9:264-271.
43. Crossley PH, Martinez S, Martin GR. 1996. Midbrain development induced by FGF8 in the chick embryo. Nature 380:66-68.
44. DeFelipe J, Farinas I. 1992. The pyramidal neuron of the cerebral cortex: Morphological and chemical characteristics of the synaptic inputs. Prog Neurobiol 39:563-607.
45. DeFelipe J, Hendry SH, Hashikawa T, et al. 1990. A microcolumnar structure of monkey cerebral cortex revealed by immunocytochemical studies of double bouquet cell axons. Neuroscience 37:655-673.
46. Eddison M, Toole L, Bell E, et al. 2004. Segmental identity and cerebellar granule cell induction in rhombomere 1. BMC Biol 2:14.
47. Ernst M, Zametkin AJ, Matochik JA, et al. 1997. Low medial prefrontal dopaminergic activity in autistic children. Lancet 350:638.
48. Fatemi SH, Halt AR, Stary JM, et al. 2002. Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices. Biol Psychiatry 52:805-810.
49. Fode C, Ma Q, Casarosa S, et al. 2000. A role for neural determination genes in specifying the dorsoventral identity of telencephalic neurons. Genes Dev 14:67-80.
50. Folstein SE, Rosen-Sheidley B. 2001. Genetics of autism: Complex aetiology for a heterogeneous disorder. Nat Rev Genet 2:943-955.
51. Freund TF. 2003. Interneuron diversity series: Rhythm and mood in perisomatic inhibition. Trends Neurosci 26:489-495.
52. Freund TF, Buzsaki G. 1996. Interneurons of the hippocampus. Hippocampus 6:347-470.
53. Gharani N, Benayed R, Mancuso V, et al. 2004. Association of the homeobox transcription factor, ENGRAILED 2, 3, with autism spectrum disorder. Mol Psychiatry 9:474-484.
54. Grove EA, Tole S, Limon J, et al. 1998. The hem of the embryonic cerebral cortex is defined by the expression of multiple Wnt genes and is compromised in Gli3-deficient mice. Development 125:2315-2325.
55. Guo S, Brush J, Teraoka H, et al. 1999. Development of noradrenergic neurons in the zebrafish hindbrain requires BMP, FG F8, and the homeodomain protein soulless/Phox2a. Neuron 24:555-566.
56. Hardan AY, Minshew NJ, Keshavan MS. 2000. Corpus callosum size in autism. Neurology 55(7):1033-1036.
57. Hariri AR, Mattay VS, Tessitore A, et al. 2002. Serotonin transporter genetic variation and the response of the human amygdala. Science 297:400-403.
58. Hariri AR, Weinberger DR. 2003. Functional neuroimaging of genetic variation in serotonergic neurotransmission. Genes Brain Behav 2:341-349.
59. Hashimoto T, Tayama M, Murakawa K, et al. 1995. Development of the brainstem and cerebellum in autistic patients. J Autism Dev Disord 25:1-18.
60. Hillbrand M, Waite BM, Miller DS, et al. 2000. Serum cholesterol concentrations and mood states in violent psychiatric patients: An experience sampling study. J Behav Med 23:519-529.
61. Holopainen IE, Kokkonen H, Korpi ER. 2001a. Angelman syndrome: From the phenotype of a developmental disorder to the genes. Duodecim 117:383-387.
62. Holopainen IE, Metsahonkala EL, Kokkonen H, et al. 2001b. Decreased binding of [11C]flumazenil in Angelman syndrome patients with GABA(A) receptor beta3 subunit deletions. Ann Neurol 49:110-113.
63. Hussman JP. 2001. Suppressed GABAergic inhibition as a common factor in suspected etiologies of autism. J Autism Dev Disord 31:247-248.
64. Hynes M, Rosenthal A. 1999. Specification of dopaminergic and serotonergic neurons in the vertebrate CNS. Curr Opin Neurobiol 9:26-36.
65. IMGSAC. 1998. A full genome screen for autism with evidence for linkage to a region on chromsome 7q. International Molecular Genetic Study of Autism Consortium. Hum Mol Genet 7:571-578.
66. IMGSAC. 2001. A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am J Hum Genet 69:570-581.
67. Ichtchenko K, Hata Y, Nguyen T, et al. 1995. Neuroligin 1: A splice site-specific ligand for beta-neurexins. Cell 81:435-443.
68. Jamain S, Betancur C, Quach H, et al. 2002. Linkage and association of the glutamate receptor 6 gene with autism. Mol Psychiatry 7:302-310.
69. Jamain S, Quach H, Betancur C, et al. 2003. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 34:27-29.
70. Jaszai J, Reifers F, Picker A, et al. 2003. Isthmus-to-midbrain transformation in the absence of midbrain-hindbrain organizer activity. Development 130:6611-6623.
71. Jessell TM. 2000. Neuronal specification in the spinal cord: Inductive signals and transcriptional codes. Nat Rev Genet 1:20-29.
72. Jones EG. 2000. Microcolumns in the cerebral cortex. Proc Natl Acad Sci U S A 97:5019-5021.
73. Jones MB, Palmour RM, Zwaigenbaum L, et al. 2004. Modifier effects in autism at the MAO-A and DBH loci. Am J Med Genet 126B:58-65.
74. Joyner AL, Herrup K, Auerbach BA, et al. 1991. Subtle cerebellar phenotype in mice homozygous for a targeted deletion of the En-2 homeobox. Science 251:1239-1243.
75. Just MA, Cherkassky VL, Keller TA, et al. 2004. Cortical activation and synchronization during sentence comprehension in high-functioning autism: Evidence of underconnectivity. Brain 127(Pt 8):1811-1821.
76. Kanner, L. 1943. Autistic disturbances of affective contact. Nervous Child. 2:217-250.
77. Kaplan DR, Miller FD. 2000. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10:381-391.
78. Kitamura K, Yanazawa M, Sugiyama N, et al. 2002. Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans. Nat Genet 32:359-369.
79. Klauck SM, Poustka F, Benner A, et al. 1997. Serotonin transporter (5-HTT) gene variants associated with autism?. Hum Mol Genet 6:2233-2238.
80. Korvatska E, Van de Water J, Anders TF, et al. 2002. Genetic and immunologic considerations in autism. Neurobiol Dis 9:107-125.
81. Kuemerle B, Zanjani H, Joyner A, et al. 1997. Pattern deformities and cell loss in Engrailed-2 mutant mice suggest two separate patterning events during cerebellar development. J Neurosci 17:7881-7889.
82. Lainhart JE, Piven J, Wzorek M, et al. 1997. Macrocephaly in children and adults with autism. J Am Acad Child Adolesc Psychiatry 36:282-290.
83. Lake CR, Ziegler MG, Murphy DL. 1977. Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism. Arch Gen Psychiatry 34:553-556.
84. Lam CS, Sleptsova-Friedrich I, Munro AD, et al. 2003. SHH and FGF8 play distinct roles during development of noradrenergic neurons in the locus coeruleus of the zebrafish. Mol Cell Neurosci 22:501-515.
85. Lauder JM. 1993. Neurotransmitters as growth regulatory signals: Role of receptors and second messengers. Trends Neurosci 16:233-240.
86. Lauder JM. 1990. Ontogeny of the serotonergic system in the rat: Serotonin as a developmental signal. Ann N Y Acad Sci 600:297-314.
87. Lauritsen MB, Nyegaard M, Betancur C, et al. 2003. Analysis of transmission of novel polymorphisms in the somatostatin receptor 5 (SSTR5) gene in patients with autism. Am J Med Genet 1216:100-104.
88. Laumonnier F, Bonnet-Brilhault F, Gomot M, et al. 2004. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 74:552-557.
89. Lavdas AA, Grigoriou M, Pachnis V, et al. 1999. The medial ganglionic eminence gives rise to a population of early neurons in the developing cerebral cortex. J Neurosci 19:7881-7888.
90. Lee M, Martin-Ruiz C, Graham A, et al. 2002. Nicotinic receptor abnormalities in the cerebellar cortex in autism. Brain 125(Pt 7):1483-1495.
91. Letinic K, Zoncu R, Rakic P. 2002. Origin of GABAergic neurons in the human neocortex. Nature 417:645-649.
92. Levitt P, Eagleson KL, Powell EM. 2004. Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders. Trends Neurosci 27:400-406.
93. Lewine JD, Andrews R, Chez M, et al. 1999. Magnetoencephalographic patterns of epileptiform activity in children with regressive autism spectrum disorders. Pediatrics 104(3 Pt 1):405-418.
94. Lewis DA, Levitt P. 2002. Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 25:409-432.
95. Lijam N, Paylor R, McDonald MP, et al. 1997. Social interaction and sensorimotor gating abnormalities in mice lacking Dv11. Cell 90: 895-905.
96. Liu J, Nyholt DR, Magnussen P, et al. 2001. A genomewide screen for autism susceptibility loci. Am J Hum Genet 69:327-340.
97. Longo I, Russo L, Meloni I, et al. 2004. Three Rett patients with both MECP2 mutation and 15q11-13 rearrangements. Eur J Hum Genet 12:682-685.
98. Luddens H, Korpi ER, Seeburg PH. 1995. GABAA/benzodiazepine receptor heterogeneity: Neurophysiological implications. [Review]. Neuropharmacology 34:245-254.
99. Luo X, Persico A, Lauder J. 2003. Serotonergic regulation of somatosensory cortical development: Lessons from genetic mouse models. Dev Neurosci 25:173-183.
100. Lyuksyutova AI, Lu CC, Milanesio N, et al. 2003. Anterior-posterior guidance of commissural axons by Wnt-frizzled signaling. Science 302: 1984-1988.
101. Maestrini E, Lai C, Marlow A, et al. 1999. Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. The International Molecular Genetic Study of Autism Consortium. Am J Med Genet 88: 492-496.
102. Manes F, Piven J, Vrancic D, et al. 1999. An MRI study of the corpus callosum and cerebellum in mentally retarded autistic individuals. J Neuropsychiatry Clin Neurosci 11(4):470-474.
103. Mann MR, Bartolomei MS. 1999. Towards a molecular understanding of Prader-Willi and Angelman syndromes. Hum Mol Genet 8:1867-1873.
104. Marin O, Rubenstein JL. 2001. A long, remarkable journey: Tangential migration in the telencephalon. Nat Rev Neurosci 2:780-790.
105. Martineau J, Herault J, Petit E, et al. 1994. Catecholaminergic metabolism and autism. Dev Med Child Neurol 36:688-697.
106. Martin-Ruiz CM, Lee M, Perry RH, et al. 2004. Molecular analysis of nicotinic receptor expression in autism. Brain Res Mol Brain Res 123:81-90.
107. McAllister AK, Katz LC, Lo DC. 1996. Neurotrophin regulation of cortical dendritic growth requires activity. Neuron 17:1057-1064.
108. McAUister AK, Katz LC, Lo DC. 1997. Opposing roles for endogenous BDNF and NT-3 in regulating cortical dendritic growth. Neuron 18:767-778.
109. McAllister AK, Lo DC, Katz LC. 1995. Neurotrophins regulate dendritic growth in developing visual cortex. Neuron 15:791-803.
110. McCoy PA, Shao Y, Wolpert CM, et al. 2002. No association between the WNT2 gene and autistic disorder. Am J Med Genet 114:106-109.
111. McDougle CJ, Posey D. 2002. Genetics of childhood disorders: XLIV. Autism, part 3: Psychopharmacology of autism. J Am Acad Child Adolesc Psychiatry 41:1380-1383.
112. Millen KJ, Wurst W, Herrup K, et al. 1994. Abnormal embryonic cerebellar development and patterning of postnatal foliation in two mouse Engrailed-2 mutants. Development 120:695-706.
113. Miller MW. 1985. Cogeneration of retrogradely labeled corticocortical projection and GABA-immunoreactive local circuit neurons in cerebral cortex. Brain Res 355:187-192.
114. Miller MW. 1986. The migration and neurochemical differentiation of gamma-aminobutyric acid (GABA)-immunoreactive neurons in rat visual cortex as demonstrated by a combined immunocytochemical-autoradiographic technique. Brain Res 393:41-46.
115. Miyazaki K, Narita N, Sakuta R, et al. 2004. Serum neurotrophin concentrations in autism and mental retardation: A pilot study. Brain Dev 26:292-295.
116. Morin X, Cremer H, Hirsch MR, et al. 1997. Defects in sensory and autonomie ganglia and absence of locus coeruleus in mice deficient for the homeobox gene Phox2a. Neuron 18: 411-423.
117. Mountcastle VB. 1997. The columnar organization of the neocortex. Brain 120(Pt 4):701-722.
118. Muhle R, Trentacoste SV, Rapin I. 2004. The genetics of autism. Pediatrics 113:e472-e486.
119. Nabi R, Serajee FJ, Chugani DC, et al. 2004. Association of tryptophan 2,3 dioxygenase gene polymorphism with autism. Am J Med Genet 125B:63-68.
120. Nelson KB, Grether JK, Croen LA, et al. 2001. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol 49:597-606.
121. Nery S, Fishell G, Corbin JG. 2002. The caudal ganglionic eminence is a source of distinct cortical and subcortical cell populations. Nat Neurosci 5:1279-1287.
122. Nilsson M, Waters S, Waters N, et al. 2001. A behavioural pattern analysis of hypoglutamatergic mice: Effects of four different antipsychotic agents. J Neural Transm 108:1181-1196.
123. Nurmi EL, Amin T, Olson LM, et al. 2003. Dense linkage disequilibrium mapping in the 15q11-q13 maternal expression domain yields evidence for association in autism. Mol Psychiatry 8:570.
124. Pattyn A, Goridis C, Brunei JF. 2000. Specification of the central noradrenergic phenotype by the homeobox gene Phox2b. Mol Cell Neurosci 15:235-243.
125. Pattyn A, Morin X, Cremer H, et al. 1999. The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives. Nature 399:366-370.
126. Pattyn A, Simplicio N, Van Doorninck JH, et al. 2004. Asc11/Mash1 is required for the development of central serotonergic neurons. Nat Neurosci 7:589-595.
127. Perry EK, Lee ML, Martin-Ruiz CM, et al. 2001. Cholinergic activity in autism: Abnormalities in the cerebral cortex and basal forebrain. Am J Psychiatry 158:1058-1066.
128. Persico AM, D'Agruma L, Zelante L, et al. 2004. Enhanced APOE2 transmission rates in families with autistic probands. Psychiatr Genet 14:73-82.
129. Persico AM, Militerni R, Bravaccio C, et al. 2000. Lack of association between serotonin transporter gene promoter variants and autistic disorder in two ethnically distinct samples. Am J Med Genet 96:123-127.
130. Persico AM, Pascucci T, Puglisi-Allegra S, et al. 2002. Serotonin transporter gene promoter variants do not explain the hyperserotoninemia in autistic children. Mol Psychiatry 7:795-800.
131. Pescucci C, Meloni I, Bruttini M, et al. 2003. Chromosome 2 deletion encompassing the MAP2 gene in a patient with autism and Rett-like features. Clin Genet 64:497-501.
132. Peters AR. 1994. Primary visual cortex of primates. In: Peters AR, Rockland K. S., editor. Cerebral Cortex. New York: Plenum, p 1-36.
133. Peters A, Sethares C. 1996. Myelinated axons and the pyramidal cell modules in monkey primary visual cortex. J Comp Neurol 365:232-255.
134. Philippe A, Martinez M, Guilloud-Bataille M, et al. 1999. Genome-wide scan for autism susceptibility genes. Human Molecular Genetics 8:805-812.
135. Piven J. 1997. The biological basis of autism. Curr Opin Neurobiol 7:708-712.
136. Piven J. 2004. Preface. Ment Retard Dev Disabil Res Rev 10:219-220
137. Piven J, Arndt S, Bailey J, et al. 1995. An MRI study of brain size in autism. Am J Psychiatry 152:1145-1149.
138. Piven J, Nehme E, Simon J, et al. 1992. Magnetic resonance imaging in autism: Measurement of the cerebellum, pons, and fourth ventricle. Biol Psychiatry 31:491-504.
139. Piven J, Saliba K, Bailey J, et al. 1997. An MRI study of autism: The cerebellum revisited. Neurology 49:546-551.
140. Polleux F, Whitford KL, Dijkhuizen PA, et al. 2002. Control of cortical interneuron migration by neurotrophins and PI3-kinase signaling. Development 129:3147-3160.
141. Portbury AL, Chandra R, Groelle M, et al. 2003. Catecholamines act via a beta-adrenergic receptor to maintain fetal heart rate and survival. Am J Physiol Heart Circ Physiol 284: H2069-H2077.
142. Powell EM, Campbell DB, Stanwood GD, et al. 2003. Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J Neurosci 23:622-631.
143. Powell EM, Mars WM, Levitt P. 2001. Hepatocyte growth factor/scatter factor is a motogen for interneurons migrating from the ventral to dorsal telencephalon. Neuron 30:79-89.
144. Purcell AE, Jeon OH, Zimmerman AW, et al. 2001. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 57:1618-1628.
145. Rakic P. 1972. Mode of cell migration to the superficial layers of fetal monkey neocortex. J Comp Neurol 145:61-83.
146. Ramanathan S, Woodroffe A, Flodman PL, et al. 2004. A case of autism with an interstitial deletion on 4q leading to hemizygosity for genes encoding for glutamme and glycine neurotransmitter receptor sub-units (AMPA2, GLRA3, GLRB) and neuropeptide receptors NPY1R, NPY5R. BMC Med Genet 5:10.
147. Ramoz N, Reichert JG, Smith CJ, et al. 2004. Linkage and association of the mitochondrial aspartate/glutamate carrier SLC25A12 gene with autism. Am J Psychiatry 161:662-669.
148. Raymond GV, Bauman ML, Kemper TL. 1996. Hippocampus in autism: A Golgi analysis. Acta Neuropathol (Berl) 91:117-119. Roscj M. Spiker D, Lotspeich L, et al. 1999. A genomic screen of autism: evidence for a multilocus etiiology. Am J Hum Genet 65:493-507.
149. Raymond GV, Bauman ML, Kemper TL. 1996. Hippocampus in autism: A Golgi analysis. Acta Neuropathol (Berl) 91:117-119. Roscj M. Spiker D, Lotspeich L, et al. 1999. A genomic screen of autism: evidence for a multilocus etiiology. Am J Hum Genet 65:493-507.
150. Risch N, Spiker D, Lotspeich L, et al. 1999. A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet 65:493-507.
151. Robinson PD, Schutz CK, Macciardi F, et al. 2001. Genetically determined low maternal serum dopamine beta-hydroxylase levels and the etiology of autism spectrum disorders. Am J Med Genet 100:30-36.
152. Rodier PM, Ingram JL, Tisdale B, et al. 1996. Embryological origin for autism: Developmental anomalies of the cranial nerve motor nuclei. J Comp Neurol 370:247-261.
153. Roffler-Tarlov S, Rios M. 2001. Catecholamines before nervous sctivity. In: Kalverboer AF, Gramsbergen A, editors. Handbook of Brain and Human Development. Dordrecht/Boston/London: Kluwer Academic Publishers, p 165-184.
154. Rubenstein JL, Merzenich MM. 2003. Model of autism: Increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2:255-267.
155. Scanlon SM, Williams DC, Schloss P. 2001. Membrane cholesterol modulates serotonin transporter activity. Biochemistry 40:10507-10513.
156. Schumann CM, Hamstra J, Goodlin-Jones BL, et al. 2004. The amygdala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages. J Neurosci 24:6392-6401.
157. Schuurmans C, Armant O, Nieto M, et al. 2004. Sequential phases of cortical specification involve Neurogenin-dependent and -independent pathways. Embo J 23:2892-2902.
158. Schuurmans C, Guillemot F. 2002. Molecular mechanisms underlying cell fate specification in the developing telencephalon. Curr Opin Neurobiol 12:26-34.
159. Sears LL, Vest C, Mohamed S, et al. 1999. An MRI study of the basal ganglia in autism. Prog Neuropsychopharmacol Biol Psychiatry 23: 613-624.
160. Serajee FJ, Zhong H, Nabi R, et al. 2003. The metabotropic glutamate receptor 8 gene at 7q31: Partial duplication and possible association with autism. J Med Genet 40:e42.
161. Shahbazian M, Young J, Yuva-Paylor L, et al. 2002. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35: 243-254.
162. Shao Y, Cuccaro ML, Hauser ER, et al. 2003. Fine mapping of autistic disorder to chromosome 15q11-q13 by use of phenotypic subtypes. Am J Hum Genet 72:539-548.
163. Sherr EH. 2003. The ARX story (epilepsy, mental retardation, autism, and cerebral malformations): One gene leads to many phenotypes. Curr Opin Pediatr 15:567-571.
164. Shieh PB, Ghosh A. 1997. Neurotrophins: New roles for a seasoned cast. Curr Biol 7:R627-R630.
165. Sidman RL, Rakic P. 1973. Neuronal migration, with special reference to developing human brain: A review. Brain Res 62:1-35.
166. Simon HH, Bhatt L, Gherbassi D, et al. 2003. Midbrain dopaminergic neurons: Determination of their developmental fate by transcription factors. Ann N Y Acad Sci 991:36-47.
167. Smidt MP, Smits SM, Burbach JP. 2003. Molecular mechanisms underlying midbrain dopamine neuron development and function. Eur J Pharmacol 480:75-88.
168. Smith M, Filipek PA, Wu C, et al. 2000. Analysis of a 1-megabase deletion in 15q22-q23 in an autistic patient: identification of candidate genes for autism and of homologous DNA segments in 15q22-q23 and 15q11-q13. Am J Med Genet 96:765-770.
169. Song JY, Ichtchenko K, Sudhof TC, et al. 1999. Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses. Proc Natl Acad Sci U S A 96:1100-1105.
170. Sparks BF, Friedman SD, Shaw DW, et al. 2002. Brain structural abnormalities in young children with autism spectrum disorder. Neurology 59:184-192.
171. Spitzer NC, Root CM, Borodinsky LN. 2004. Orchestrating neuronal differentiation: Patterns of Ca(2+) spikes specify transmitter choice. Trends Neurosci 27:415-421.
172. Steg JP, Rapoport JL. 1975. Minor physical anomalies in normal, neurotic, learning disabled, and severely disturbed children. J Autism Child Schizophr 5:299-307.
173. Stevenson RE, Schroer RJ, Skinner C, et al. 1997. Autism and macrocephaly. Lancet 349(9067): 1744-1745.
174. Stokstad E. 2001. Development: New hints into the biological basis of autism. Science 294: 34-37.
175. Sultana R, Yu CE, Yu J, et al. 2002. Identification of a novel gene on chromosome 7q11.2 interrupted by a translocation breakpoint in a pair of autistic twins, Genomics 80:129-134.
176. Tallon-Baudry C, Bertrand O. 1999. Oscillatory gamma activity in humans and its role in object representation. Trends Cogn Sci 3:151-162.
177. Tamamaki N, Fujimori KE, Takauji R. 1997. Origin and route of tangentially migrating neurons in the developing neocortical intermediate zone. J Neurosci 17:8313-8323.
178. Thomas SA, Marck BT, Palmiter RD, et al. 1998. Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine beta-hydroxylase. J Neurochem 70:2468-2476.
179. Thomas SA, Matsumoto AM, Palmiter RD. 1995. Noradrenaline is essential for mouse fetal development. Nature 374:643-646.
180. Thomas NS, Sharp AJ, Browne CE, et al. 1999. Xp deletions associated with autism in three females. Hum Genet 104:43-48.
181. Tordjman S, Gutknecht L, Carlier M, et al. 2001. Role of the serotonin transporter gene in the behavioral expression of autism. Mol Psychiatry 6:434-439.
182. Trottier G, Srivastava L, Walker CD. 1999. Etiology of infantile autism: A review of recent advances in genetic and neurobiological research. J Psychiatry Neurosci 24:103-115.
183. Tuchman R. 2003. Autism. Neurol Clin 21:915-932, viii.
184. Veenstra-VanderWeele J, Anderson GM, Cook EH Jr. 2000. Pharmacogenetics and the serotonin system: Initial studies and future directions. Eur J Pharmacol 410:165-181.
185. Veenstra-Vanderweele J, Cook E Jr., Lombroso PJ. 2003. Genetics of childhood disorders: XLVI. Autism, part 5: Genetics of autism. J Am Acad Child Adolesc Psychiatry 42:116-118.
186. Veenstra-VanderWeele J, Cook EH. 2004. Molecular genetics of autism spectrum disorder. Mol Psychiatry 9:819-832.
187. Veenstra-VanderWeele J, Kim SJ, Lord C, et al. 2002. Transmission disequilibrium studies of the serotonin 5-HT2A receptor gene (HTR2A) in autism. Am J Med Genet 114: 277-283.
188. Veltman MW, Thompson RJ, Roberts SE, et al. 2004. Prader-Willi Syndrome - a study comparing deletion and uniparental disomy cases with reference to autism spectrum disorders. Eur Child Adolesc Psychiatry 13:42-50.
189. Vervoort VS, Beachem MA, Edwards PS, et al. 2002. AGTR2 mutations in X-linked mental retardation. Science 296:2401-2403.
190. Vogel-Hopker A, Rohrer H. 2002. The specification of noradrenergic locus coeruleus (LC) neurones depends on bone morphogenetic proteins (BMPs). Development 129:983-991.
191. Volkmar FR. 2001. Pharmacological interventions in autism: Theoretical and practical issues. J Clin Child Psychol 30:80-87.
192. Waage-Baudet H, Lauder JM, Dehart DB, et al. 2003. Abnormal serotonergic development in a mouse model for the Smith-Lemli-Opitz syndrome: Implications for autism. Int J Dev Neurosci 21:451-459.
193. Wassink TH, Brzustowicz LM, Bartlett CW, Szatmari P. 2004. The search for autism disease genes. Ment Retard Dev Disabil Res Rev 10:272-283.
194. Wassink TH, Piven J, Vieland VJ, et al. 2001. Evidence supporting WNT2 as an autism susceptibility gene. Am J Med Genet 105:406-413.
195. Whitaker-Azmitia PM. 2001. Serotonin and brain development: Role in human developmental diseases. Brain Res Bull 56:479-485.
196. Wichterle H, Turnbull DH, Nery S, et al. 2001. In utero fate mapping reveals distinct migratory pathways and fates of neurons born in the mammalian basal forebrain. Development 128:3759-3771.
197. Wodarz A, Nusse R. 1998. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 14:59-88.
198. Wurst W, Auerbach AB, Joyner AL. 1994. Multiple developmental defects in Engrailed-1 mutant mice: An early mid-hindbrain deletion and patterning defects in forelimbs and sternum. Development 120:2065-2075.
199. Ye W, Bouchard M, Stone D, et al. 2001. Distinct regulators control the expression of the midhindbrain organizer signal FGF8. Nat Neurosci 4:1175-1181.
200. Ye W, Shimamura K, Rubenstein JL, et al. 1998. FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell 93:755-766.
201. Yirmiya N, Pilowsky T, Nemanov L, et al. 2001. Evidence for an association with the serotonin transporter promoter region polymorphism and autism. Am J Med Genet 105:381-386.
202. Yu X, Malenka RC. 2003. Beta-catenin is critical for dendritic morphogenesis. Nat Neurosci 6:1169-1177.
203. Zhou CJ, Zhao C, Pleasure SJ. 2004. Wnt signaling mutants have decreased dentate granule cell production and radial glial scaffolding abnormalities. J Neurosci 24:121-126.
204. Zoghbi HY. 2003. Postnatal neurodevelopmental disorders: Meeting at the synapse? Science 302:826-830.